Literature DB >> 27074084

Multiple Sclerosis and Antibodies against KIR4.1.

Anne-Katrin Pröbstel1, Jens Kuhle1, Anne-Catherine Lecourt1, Isabelle Vock1, Nicholas S R Sanderson1, Ludwig Kappos1, Tobias Derfuss1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27074084     DOI： 10.1056/NEJMc1507131

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  The tension between early diagnosis and misdiagnosis of multiple sclerosis.

Authors:  Andrew J Solomon; John R Corboy
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

Review 2.  Biomarkers in Multiple Sclerosis.

Authors:  Anu Paul; Manuel Comabella; Roopali Gandhi
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 3.  Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept.

Authors:  Romana Höftberger; Hans Lassmann; Thomas Berger; Markus Reindl
Journal:  Nat Rev Neurol       Date:  2022-08-15       Impact factor: 44.711

Review 4.  An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis.

Authors:  Marwa Kaisey; Ghazal Lashgari; Justyna Fert-Bober; Daniel Ontaneda; Andrew J Solomon; Nancy L Sicotte
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-21       Impact factor: 6.030

5.  G protein-coupled receptors differentially regulate glycosylation and activity of the inwardly rectifying potassium channel Kir7.1.

Authors:  Sheridan J Carrington; Ciria C Hernandez; Daniel R Swale; Oluwatosin A Aluko; Jerod S Denton; Roger D Cone
Journal:  J Biol Chem       Date:  2018-09-26       Impact factor: 5.157

6.  Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.

Authors:  Anne Chastre; David A Hafler; Kevin C O'Connor
Journal:  N Engl J Med       Date:  2016-04-14       Impact factor: 91.245

Review 7.  KIR4.1: K+ Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis.

Authors:  Chen Gu
Journal:  Front Mol Neurosci       Date:  2016-09-27       Impact factor: 5.639

8.  Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.

Authors:  Miquel Navas-Madroñal; Ana Valero-Mut; María José Martínez-Zapata; Manuel Javier Simón-Talero; Sebastián Figueroa; Nuria Vidal-Fernández; Mariana López-Góngora; Antonio Escartín; Luis Querol
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

Review 9.  B cells in autoimmune and neurodegenerative central nervous system diseases.

Authors:  Joseph J Sabatino; Anne-Katrin Pröbstel; Scott S Zamvil
Journal:  Nat Rev Neurosci       Date:  2019-11-11       Impact factor: 34.870

Review 10.  Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Joseph A Lopez; Martina Denkova; Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Clin Transl Immunology       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.